Target intelligence / Profile preview

Broad-spectrum toxins

Molecular classification
Protein, Lipopolysaccharide, Virulence factor, Exotoxin
01

Overview

Broad-spectrum toxins are a diverse class of virulence factors produced by various pathogens, including bacteria and fungi, that exert deleterious effects on a wide range of host cells and tissues (NIH, 2023). These toxins function through several mechanisms, such as forming pores in cell membranes, enzymatically modifying host proteins, or overstimulating the immune system to cause systemic inflammation (Nature Reviews Microbiology, 2021). In a therapeutic context, these toxins are targeted by neutralizing agents like monoclonal antibodies or polyvalent antitoxins to mitigate disease severity and improve patient outcomes (StatPearls, 2024). Because the term broad-spectrum toxins refers to a functional category rather than a single molecular entity, it encompasses a variety of structural classes, including A-B toxins and superantigens (PubMed, 2022). The development of broad-spectrum antitoxins, such as those using nanoparticle-based decoys or cross-reactive antibodies, represents an emerging strategy to neutralize multiple toxin types simultaneously (Nature Nanotechnology, 2020). Targeting these molecules is essential for managing conditions like anthrax, botulism, and Clostridioides difficile-associated diarrhea, where the toxin itself is the primary driver of pathology (CDC, 2023).

Other names
Bacterial toxinsVirulence factorsExotoxinsEndotoxinsMicrobial toxins
02

Mechanism of action

Neutralization of toxin activity by preventing binding to host cell receptors, inhibiting enzymatic activity, or blocking the translocation of the toxin into the cytoplasm (StatPearls, 2024).

03

Biological functions

PathogenesisCytolysisInhibition of protein synthesisImmune evasionDisruption of cell signaling
04

Disease associations

InfectionSepsisToxic shock syndromeFood poisoningAnthraxBotulism
05

Safety considerations

AnaphylaxisSerum sicknessImmunogenicityIncomplete neutralization of toxin variantsRapid toxin release during bacterial lysis
06

Interacting drugs

Bezlotoxumab

6 more in the full profile.

07

Biomarkers

Serum toxin levelsToxin-specific ELISA titersPCR for toxin genesC-reactive protein (CRP)

Beyond the preview

Go deeper on Broad-spectrum toxins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Broad-spectrum toxins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call